National Marrow Donor Program/Be The Match forms new cellular therapies subsidiary

January 22, 2016

MINNEAPOLIS--January 22, 2016--The National Marrow Donor Program® (NMDP) /Be The Match®, the national organization that connects patients with their donor match for a life-saving bone marrow or umbilical cord blood transplant, today announced the formation of Be The Match BioTherapiesSM, a subsidiary that will focus on partnering with organizations pursuing new life-saving treatments in cellular therapy.

For more than 25 years, the NMDP/Be The Match has provided services and expertise in the field of cellular therapy through the facilitation of 74,000 transplants. Be The Match BioTherapies will extend these unique capabilities to organizations developing and providing new cellular therapies, enabling these organizations to help critically ill patients who can benefit from these new treatments.

"We have a long-standing commitment to pursuing and providing innovative, life-saving therapies and services," said Jeffrey Chell, M.D., Chief Executive Officer of the NMDP/Be The Match and Be The Match BioTherapies. "We are entering this exciting field as a natural extension of our current mission to save lives. If the services and expertise we've built over the course of our history can help patients in new ways, we feel it's our obligation to help."

Cellular therapies, including marrow and cord blood transplant, are specialized patient treatments that are made from cells collected from the patient or an adult donor, often used to assist the patient's immune system. New types of cellular therapies can help patients for whom transplant isn't an option and address post-transplant issues such as life-threatening infection or relapse. These new therapies will treat patients with blood cancer, solid tumors and other conditions. As more is learned, much more can be done to treat cancer and other critical conditions.

Dr. Chell concluded, "While continuing our unwavering focus on transplantation, we look forward to partnering in this innovative field."
About the National Marrow Donor Program® (NMDP)/Be The Match®

The National Marrow Donor Program (NMDP)/Be The Match is the global leader in providing a cure to patients with life-threatening blood and marrow cancers such as leukemia and lymphoma, as well as other diseases. The nonprofit organization manages the world's largest registry of potential marrow donors and cord blood units, connects patients to their donor match for a life-saving marrow or umbilical cord blood transplant, educates health care professionals and conducts research through its research program, CIBMTR® (Center for International Blood and Marrow Transplant Research®),so more lives can be saved. NMDP/Be The Match also provides patient support and enlists the community to join the Be The Match Registry®, contribute financially and volunteer.

To learn more about the cure, visit or call 1 (800) MARROW-2.

National Marrow Donor Program (NMDP)/Be The Match

Related Cellular Therapy Articles from Brightsurf:

Cellular survivors
When it comes to complex life -- that of the multicellular variety -- cell death can be just as important as survival.

Anticancer compounds for B cell cancer therapy targeting cellular stress response
Wistar and collaborators from the University of Notre Dame are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the development of multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and lymphoma.

Improving the efficacy of cellular therapies
A new study published in Nature Communications deepens the understanding of the development of T cell, an important component of the immune system.

Mysterious cellular droplets come into focus
Researchers are shedding light on a type of membrane-less organelle, known as biological condensates, that play a role in DNA repair and aging.

Cholesterol's effects on cellular membranes
The findings have far-reaching implications in the general understanding of disease, the design of drug delivery methods, and many other biological applications that require specific assumptions about the role of cholesterol in cell membranes.

Cellular stress causes cancer cell chemoresistance
Resistance of cancer cells against therapeutic agents is a major cause of treatment failure, especially in recurrent diseases.

A new understanding of everyday cellular processes
We use cells to breathe, to moderate body temperature, to grow and many other every day processes, however the cells in these processes are so complex its left scientists perplexed into how they develop in different environments.

A cellular mechanism protecting against cancer
Susanne Hellmuth and Olaf Stemmann from the University of Bayreuth have discovered a natural protective mechanism that leads to the programmed death of potentially diseased cells.

Combination creates powerful central memory T cells for cellular therapy
MD Anderson researchers find that treating T cells with panobinostat and IL-21 re-programs them to a powerful central memory T cell type that persists longer.

Changes in cellular degradation hubs can lead to cancer
Cancer cells grow and divide in an uncontrolled manner. A new study from Uppsala University now shows how alterations in a cell's degradation hubs, called lysosomes, can cause abnormal cell growth.

Read More: Cellular Therapy News and Cellular Therapy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to